\
&
Contact us
\
&
Contact us
Starts in 1 month from now
LocationLamot, Mechelen
ProgrammesThis event aims to bridge the gap between university and industry and set out the future Cybersecurity agenda. Expect thought-provoking keynotes from cybersecurity experts, real-world success stories of research valorisation, and plenty of opportunities to connect and exchange ideas.
Agenda details and registration will soon be available on this page.
This event is organised by the Research Consortium of the Cybersecurity Research Program Flanders. For more information about the organisers: cybersecurity-research.be
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
